Aberrant HLA-G expression has often been found in tumor lesions but is rare in adjacent “nontumor” tissue [73], and the expression of the nonclassical class Ib antigen in tumors has often been associated with tumor progression and a poor prognosis for cancer patients [86–89]. Here, HLA-G is linked to cancer.